474 related articles for article (PubMed ID: 28861725)
1. Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH.
Garrido P; Aldaz A; Vera R; Calleja MA; de Álava E; Martín M; Matías-Guiu X; Palacios J
Clin Transl Oncol; 2018 Apr; 20(4):443-447. PubMed ID: 28861725
[TBL] [Abstract][Full Text] [Related]
2. Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: a position statement of SEOM, SEAP and SEFH.
Garrido P; Aldaz A; Calleja MÁ; De Álava E; Lamas MJ; Martín M; Matías-Guiu X; Palacios J; Vera R
Farm Hosp; 2017 Nov; 41(6):688-691. PubMed ID: 29112494
[TBL] [Abstract][Full Text] [Related]
3. [Proposal of the SEOM, SEAP and SEFH for the creation of a National Strategy for Precision Medicine in Cancer].
Garrido P; Aldaz A; Calleja MÁ; de Álava E; Lamas MJ; Martín M; Matías-Guiu X; Palacios J; Vera R
Rev Esp Patol; 2018; 51(3):154-159. PubMed ID: 30012308
[TBL] [Abstract][Full Text] [Related]
4. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
[TBL] [Abstract][Full Text] [Related]
5. Precision medicine in oncology: New practice models and roles for oncology pharmacists.
Walko C; Kiel PJ; Kolesar J
Am J Health Syst Pharm; 2016 Dec; 73(23):1935-1942. PubMed ID: 27864201
[TBL] [Abstract][Full Text] [Related]
6. Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?
Morgan G; Aftimos P; Awada A
Curr Opin Oncol; 2016 Sep; 28(5):441-6. PubMed ID: 27428363
[TBL] [Abstract][Full Text] [Related]
7. Perspective on Precision Medicine in Oncology.
Johnson TM
Pharmacotherapy; 2017 Sep; 37(9):988-989. PubMed ID: 28632968
[TBL] [Abstract][Full Text] [Related]
8. Implementation of Precision Oncology in Clinical Practice: Results of a National Survey for Health Care Professionals.
Fasola G; Barducci MC; Pelizzari G; Grossi F; Pinto C; Daniele B; Giordano M; Ortega C; Silva RR; Tozzi VD; Cavanna L; Aprile G
Oncologist; 2023 Jun; 28(6):e324-e330. PubMed ID: 36848261
[TBL] [Abstract][Full Text] [Related]
9. Policy statement on multidisciplinary cancer care.
; Borras JM; Albreht T; Audisio R; Briers E; Casali P; Esperou H; Grube B; Hamoir M; Henning G; Kelly J; Knox S; Nabal M; Pierotti M; Lombardo C; van Harten W; Poston G; Prades J; Sant M; Travado L; Valentini V; van de Velde C; van den Bogaert S; van den Bulcke M; van Hoof E; van den Neucker I; Wilson R
Eur J Cancer; 2014 Feb; 50(3):475-80. PubMed ID: 24321260
[TBL] [Abstract][Full Text] [Related]
10. Precision medicine in breast cancer.
Naito Y; Urasaki T
Chin Clin Oncol; 2018 Jun; 7(3):29. PubMed ID: 30056731
[TBL] [Abstract][Full Text] [Related]
11. [Liquid biopsy in oncology: A consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
Álvarez-Alegret R; Rojo Todo F; Garrido P; Bellosillo B; Rodríguez-Lescure Á; Rodríguez-Peralto JL; Vera R; de Álava E; García-Campelo R; Remon J
Rev Esp Patol; 2020; 53(4):234-245. PubMed ID: 33012494
[TBL] [Abstract][Full Text] [Related]
12. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
[TBL] [Abstract][Full Text] [Related]
13. THE FUTURE OF MEDICINE, healthcare innovation through precision medicine: policy case study of Qatar.
Qoronfleh MW; Chouchane L; Mifsud B; Al Emadi M; Ismail S
Life Sci Soc Policy; 2020 Nov; 16(1):12. PubMed ID: 33129349
[TBL] [Abstract][Full Text] [Related]
14. Implementing Precision Medicine Programs and Clinical Trials in the Community-Based Oncology Practice: Barriers and Best Practices.
Ersek JL; Black LJ; Thompson MA; Kim ES
Am Soc Clin Oncol Educ Book; 2018 May; 38():188-196. PubMed ID: 30231363
[TBL] [Abstract][Full Text] [Related]
15. [Healthcare of children and adolescents in national strategy for action for children for 2012-2017].
Kuchma VR
Gig Sanit; 2013; (6):26-30. PubMed ID: 24624816
[TBL] [Abstract][Full Text] [Related]
16. Partnering with patients in translational oncology research: ethical approach.
Mamzer MF; Duchange N; Darquy S; Marvanne P; Rambaud C; Marsico G; Cerisey C; Scotté F; Burgun A; Badoual C; Laurent-Puig P; Hervé C
J Transl Med; 2017 Apr; 15(1):74. PubMed ID: 28390420
[TBL] [Abstract][Full Text] [Related]
17. [Implementing next-generation sequencing for precision hematology/oncology].
Maeda T
Rinsho Ketsueki; 2018; 59(10):1924-1934. PubMed ID: 30305493
[TBL] [Abstract][Full Text] [Related]
18. [Molecular-Genetic Diagnosis and Molecular-Targeted Therapy in Cancer: Challenges in the Era of Precision Medicine].
Miyachi H
Rinsho Byori; 2015 Oct; 63(10):1188-93. PubMed ID: 26897855
[TBL] [Abstract][Full Text] [Related]
19. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
20. Ethical considerations of neuro-oncology trial design in the era of precision medicine.
Gupta S; Smith TR; Broekman ML
J Neurooncol; 2017 Aug; 134(1):1-7. PubMed ID: 28555425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
